Danielle Zammit Joins KJT Group as Vice President, Global Access

ROCHESTER, N.Y. - Aug. 5, 2015 - PRLog -- KJT Group is pleased to announce the addition of Dr. Danielle Zammit, Vice President, Global Access.  Danielle has more than 10 years of Healthcare Economics experience, gained in large pharmaceutical company regional and global roles, as well as in academia and the consulting side. Her skills and experience include pharmaceutical/health intervention value demonstration, health economic tool development, adaptation and application, pricing strategy and reimbursement, market access (and stakeholder mapping), health policy, outcomes research, patient reported outcomes, epidemiology and matrix alignment of internal stakeholders.

Prior to joining KJT Group, Danielle was a Research Scientist at the University of Basel after spending 3 years working as a Senior Consultant on the HEOR consulting team at IMS Health. Before that, she worked in these areas within the European or global HQ of Roche, BMS and Novartis. Her key areas of expertise and special interest include the neuroscience, cardiovascular, metabolics and respiratory therapeutic areas; Alzheimer’s disease, vaccines, breast cancer, hepatitis, ophthalmics and diabetes; global and local health policy and public health.

Danielle received her Ph.D. in Pharmaceutical Economics and Policy (2007) and M.A. in Economics (2003) from the University of Southern California. She also earned a M.Sc. in Pharmacology from the University of British Columbia (1997) and first obtained a pharmacist license after studying pharmacy at the University of Malta in 1992.

“The need for experienced global experts in market access and health economics has never been more essential to our business mission.  Danielle not only has the expertise, she also boasts the creativity and client-focus needed to execute successful projects,” said Dr. Kenneth J. Tomaszewski, President and CEO of KJT Group.

Located in Switzerland, Danielle will work closely with KJT Group’s growing European practice including Mathew Francis, Research Director who joined KJT Group in June.  With more than twenty years of market research experience in the healthcare and pharmaceutical industries, Mathew is a highly experienced market research professional.

About KJT Group: KJT Group (www.kjtgroup.com) is a full service life sciences market research and insight consultancy firm. Established in 2007, KJT Group employs nearly 40 full-time staff in New York, Pennsylvania, Texas, and The Netherlands. KJT Group is a member of the European Pharmaceutical Marketing Association (EphMRA), the Pharmaceutical Marketing Research Group (PMRG), and the European Society Opinion and Marketing Research (ESOMAR) with numerous staff also members of the International Society For Pharmacoeconomics and Outcomes Research (ISPOR).